Cargando…

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

BACKGROUND: Understanding HIV-1 subtype distribution and epidemiology can assist preventive measures and clinical decisions. Sequence variation may affect antiviral drug resistance development, disease progression, evolutionary rates and transmission routes. RESULTS: We investigated the subtype dist...

Descripción completa

Detalles Bibliográficos
Autores principales: Abecasis, Ana B, Wensing, Annemarie MJ, Paraskevis, Dimitris, Vercauteren, Jurgen, Theys, Kristof, Van de Vijver, David AMC, Albert, Jan, Asjö, Birgitta, Balotta, Claudia, Beshkov, Danail, Camacho, Ricardo J, Clotet, Bonaventura, De Gascun, Cillian, Griskevicius, Algis, Grossman, Zehava, Hamouda, Osamah, Horban, Andrzej, Kolupajeva, Tatjana, Korn, Klaus, Kostrikis, Leon G, Kücherer, Claudia, Liitsola, Kirsi, Linka, Marek, Nielsen, Claus, Otelea, Dan, Paredes, Roger, Poljak, Mario, Puchhammer-Stöckl, Elisabeth, Schmit, Jean-Claude, Sönnerborg, Anders, Stanekova, Danika, Stanojevic, Maja, Struck, Daniel, Boucher, Charles AB, Vandamme, Anne-Mieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564855/
https://www.ncbi.nlm.nih.gov/pubmed/23317093
http://dx.doi.org/10.1186/1742-4690-10-7
_version_ 1782258371644096512
author Abecasis, Ana B
Wensing, Annemarie MJ
Paraskevis, Dimitris
Vercauteren, Jurgen
Theys, Kristof
Van de Vijver, David AMC
Albert, Jan
Asjö, Birgitta
Balotta, Claudia
Beshkov, Danail
Camacho, Ricardo J
Clotet, Bonaventura
De Gascun, Cillian
Griskevicius, Algis
Grossman, Zehava
Hamouda, Osamah
Horban, Andrzej
Kolupajeva, Tatjana
Korn, Klaus
Kostrikis, Leon G
Kücherer, Claudia
Liitsola, Kirsi
Linka, Marek
Nielsen, Claus
Otelea, Dan
Paredes, Roger
Poljak, Mario
Puchhammer-Stöckl, Elisabeth
Schmit, Jean-Claude
Sönnerborg, Anders
Stanekova, Danika
Stanojevic, Maja
Struck, Daniel
Boucher, Charles AB
Vandamme, Anne-Mieke
author_facet Abecasis, Ana B
Wensing, Annemarie MJ
Paraskevis, Dimitris
Vercauteren, Jurgen
Theys, Kristof
Van de Vijver, David AMC
Albert, Jan
Asjö, Birgitta
Balotta, Claudia
Beshkov, Danail
Camacho, Ricardo J
Clotet, Bonaventura
De Gascun, Cillian
Griskevicius, Algis
Grossman, Zehava
Hamouda, Osamah
Horban, Andrzej
Kolupajeva, Tatjana
Korn, Klaus
Kostrikis, Leon G
Kücherer, Claudia
Liitsola, Kirsi
Linka, Marek
Nielsen, Claus
Otelea, Dan
Paredes, Roger
Poljak, Mario
Puchhammer-Stöckl, Elisabeth
Schmit, Jean-Claude
Sönnerborg, Anders
Stanekova, Danika
Stanojevic, Maja
Struck, Daniel
Boucher, Charles AB
Vandamme, Anne-Mieke
author_sort Abecasis, Ana B
collection PubMed
description BACKGROUND: Understanding HIV-1 subtype distribution and epidemiology can assist preventive measures and clinical decisions. Sequence variation may affect antiviral drug resistance development, disease progression, evolutionary rates and transmission routes. RESULTS: We investigated the subtype distribution of HIV-1 in Europe and Israel in a representative sample of patients diagnosed between 2002 and 2005 and related it to the demographic data available. 2793 PRO-RT sequences were subtyped either with the REGA Subtyping tool or by a manual procedure that included phylogenetic tree and recombination analysis. The most prevalent subtypes/CRFs in our dataset were subtype B (66.1%), followed by sub-subtype A1 (6.9%), subtype C (6.8%) and CRF02_AG (4.7%). Substantial differences in the proportion of new diagnoses with distinct subtypes were found between European countries: the lowest proportion of subtype B was found in Israel (27.9%) and Portugal (39.2%), while the highest was observed in Poland (96.2%) and Slovenia (93.6%). Other subtypes were significantly more diagnosed in immigrant populations. Subtype B was significantly more diagnosed in men than in women and in MSM > IDUs > heterosexuals. Furthermore, the subtype distribution according to continent of origin of the patients suggests they acquired their infection there or in Europe from compatriots. CONCLUSIONS: The association of subtype with demographic parameters suggests highly compartmentalized epidemics, determined by social and behavioural characteristics of the patients.
format Online
Article
Text
id pubmed-3564855
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35648552013-02-08 HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics Abecasis, Ana B Wensing, Annemarie MJ Paraskevis, Dimitris Vercauteren, Jurgen Theys, Kristof Van de Vijver, David AMC Albert, Jan Asjö, Birgitta Balotta, Claudia Beshkov, Danail Camacho, Ricardo J Clotet, Bonaventura De Gascun, Cillian Griskevicius, Algis Grossman, Zehava Hamouda, Osamah Horban, Andrzej Kolupajeva, Tatjana Korn, Klaus Kostrikis, Leon G Kücherer, Claudia Liitsola, Kirsi Linka, Marek Nielsen, Claus Otelea, Dan Paredes, Roger Poljak, Mario Puchhammer-Stöckl, Elisabeth Schmit, Jean-Claude Sönnerborg, Anders Stanekova, Danika Stanojevic, Maja Struck, Daniel Boucher, Charles AB Vandamme, Anne-Mieke Retrovirology Research BACKGROUND: Understanding HIV-1 subtype distribution and epidemiology can assist preventive measures and clinical decisions. Sequence variation may affect antiviral drug resistance development, disease progression, evolutionary rates and transmission routes. RESULTS: We investigated the subtype distribution of HIV-1 in Europe and Israel in a representative sample of patients diagnosed between 2002 and 2005 and related it to the demographic data available. 2793 PRO-RT sequences were subtyped either with the REGA Subtyping tool or by a manual procedure that included phylogenetic tree and recombination analysis. The most prevalent subtypes/CRFs in our dataset were subtype B (66.1%), followed by sub-subtype A1 (6.9%), subtype C (6.8%) and CRF02_AG (4.7%). Substantial differences in the proportion of new diagnoses with distinct subtypes were found between European countries: the lowest proportion of subtype B was found in Israel (27.9%) and Portugal (39.2%), while the highest was observed in Poland (96.2%) and Slovenia (93.6%). Other subtypes were significantly more diagnosed in immigrant populations. Subtype B was significantly more diagnosed in men than in women and in MSM > IDUs > heterosexuals. Furthermore, the subtype distribution according to continent of origin of the patients suggests they acquired their infection there or in Europe from compatriots. CONCLUSIONS: The association of subtype with demographic parameters suggests highly compartmentalized epidemics, determined by social and behavioural characteristics of the patients. BioMed Central 2013-01-14 /pmc/articles/PMC3564855/ /pubmed/23317093 http://dx.doi.org/10.1186/1742-4690-10-7 Text en Copyright ©2013 Abecasis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Abecasis, Ana B
Wensing, Annemarie MJ
Paraskevis, Dimitris
Vercauteren, Jurgen
Theys, Kristof
Van de Vijver, David AMC
Albert, Jan
Asjö, Birgitta
Balotta, Claudia
Beshkov, Danail
Camacho, Ricardo J
Clotet, Bonaventura
De Gascun, Cillian
Griskevicius, Algis
Grossman, Zehava
Hamouda, Osamah
Horban, Andrzej
Kolupajeva, Tatjana
Korn, Klaus
Kostrikis, Leon G
Kücherer, Claudia
Liitsola, Kirsi
Linka, Marek
Nielsen, Claus
Otelea, Dan
Paredes, Roger
Poljak, Mario
Puchhammer-Stöckl, Elisabeth
Schmit, Jean-Claude
Sönnerborg, Anders
Stanekova, Danika
Stanojevic, Maja
Struck, Daniel
Boucher, Charles AB
Vandamme, Anne-Mieke
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
title HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
title_full HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
title_fullStr HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
title_full_unstemmed HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
title_short HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
title_sort hiv-1 subtype distribution and its demographic determinants in newly diagnosed patients in europe suggest highly compartmentalized epidemics
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564855/
https://www.ncbi.nlm.nih.gov/pubmed/23317093
http://dx.doi.org/10.1186/1742-4690-10-7
work_keys_str_mv AT abecasisanab hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT wensingannemariemj hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT paraskevisdimitris hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT vercauterenjurgen hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT theyskristof hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT vandevijverdavidamc hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT albertjan hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT asjobirgitta hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT balottaclaudia hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT beshkovdanail hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT camachoricardoj hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT clotetbonaventura hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT degascuncillian hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT griskeviciusalgis hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT grossmanzehava hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT hamoudaosamah hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT horbanandrzej hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT kolupajevatatjana hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT kornklaus hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT kostrikisleong hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT kuchererclaudia hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT liitsolakirsi hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT linkamarek hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT nielsenclaus hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT oteleadan hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT paredesroger hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT poljakmario hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT puchhammerstocklelisabeth hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT schmitjeanclaude hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT sonnerborganders hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT stanekovadanika hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT stanojevicmaja hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT struckdaniel hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT bouchercharlesab hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics
AT vandammeannemieke hiv1subtypedistributionanditsdemographicdeterminantsinnewlydiagnosedpatientsineuropesuggesthighlycompartmentalizedepidemics